- Lue, Tom;
- Ning, H;
- Lei, HE;
- Xu, YD;
- Guan, RL;
- Venstrom, JM;
- Lin, G;
- Lue, TF;
- Xin, Z;
- Lin, CS
Efforts to develop peripheral blood-derived nature killer (NK) cells into therapeutic products have been hampered by these cells' low abundance and histoincompatibility. On the other hand, derivation of NK-like cells from more abundant cell sources such as